As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Health In Tech, Inc. The largest reported stake is Lytton Laurence W's, at 6.2%. One filing is on record since September 29, 2026 (Schedule 13G, September 29, 2026).
Sell to companies like Health In Tech, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Lytton Laurence W · Sole voting: 0 · Shared voting: 3,317,030 · Sole dispositive: 0 · Shared dispositive: 3,317,030 · SCHEDULE 13G, 2026-09-29
- · Holder: Lytton Laurence W · Percent: 6.2% · SCHEDULE 13G
- · Holder: Lytton Laurence W · Percent: 6.2% · Shares: 3,317,030 · SCHEDULE 13G
Health In Tech, Inc. has 1 Schedule 13D or 13G filing on record since 2026-09-29. 1 holder's latest filing reports 5% or more of class a common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 6.2% | 3,317,030 | SCHEDULE 13G, 2026-09-29 | 2026-03-27 |
Holding shares or following this stake? See who's behind Health In Tech, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Health In Tech, Inc. and the records around it.
Health In Tech, Inc. elsewhere on the record
- Leadership changes May 2026
- Who owns it
Companies that share a holder
- LYTTON LAURENCE W also filed stake reports on 28 other companies: Retension Pharmaceuticals, Inc. (Oct 2026), Rank One Computing Corp (Aug 2026), MDxHealth SA (Aug 2026)
Watch Health In Tech, Inc.
Get an email when Health In Tech, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Health In Tech, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Health In Tech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Health In Tech, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Lytton Laurence W | 0 | 3,317,030 | 0 | 3,317,030 | SCHEDULE 13G, 2026-09-29 |
The latest filing identifies Health In Tech, Inc. by CUSIP 42217D102 and gives its principal executive office as 701 S. COLORADO AVE, SUITE 1, STUART, FL 34994 (SCHEDULE 13G, 2026-09-29).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-09-29 | Lytton Laurence W | 6.2% | SCHEDULE 13G |
Also on the record for Health In Tech, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 26, 2026 | Leadership change: Sanjay Shrestha appointed, Chief Executive Officer | — | Leadership changes | Source |
| May 1, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| December 23, 2024 | IPO filing, Form 424B4 | $4 a share | IPO filings | Source |
| December 17, 2024 | IPO filing, Form S-1/A | — | IPO filings | Source |
| November 19, 2024 | IPO filing, Form S-1/A | $4 to $5 a share | IPO filings | Source |
| November 6, 2024 | IPO filing, Form S-1/A | $4 to $5 a share | IPO filings | Source |
| October 11, 2024 | IPO filing, Form S-1/A | — | IPO filings | Source |
| October 3, 2024 | IPO filing, Form S-1/A | $4 to $5 a share | IPO filings | Source |
| September 24, 2024 | IPO filing, Form S-1/A | $4 to $5 a share | IPO filings | Source |
| August 30, 2024 | IPO filing, Form S-1 | $4 to $5 a share | IPO filings | Source |
Tools for this story
Each opens in a new tab, filled in for Health In Tech, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.